|
Market Closed -
Nasdaq
00:00:00 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 61.41 USD | +0.92% |
|
+0.13% | +58.93% |
| 08-13 | Zealand Pharma sells rusfertide rights for $100m | FW |
| 08-13 | Zealand Pharma to Sell Rusfertide-linked Economics to Royalty Pharma for $100 Million | MT |
| Market Cap | 27.1B 23.33B 21.9B 20B 37.54B 2,578B 37.82B 259B 101B 1,308B 102B 99.51B 4,329B | P/E 2026 * |
24.9x | P/E 2027 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 36.21B 31.17B 29.27B 26.73B 50.16B 3,445B 50.53B 347B 135B 1,748B 136B 133B 5,784B | EV / Sales 2026 * |
10.4x | EV / Sales 2027 * | 9.53x |
| Free-Float |
72.41% | Yield 2026 * |
1.65% | Yield 2027 * | 1.74% |
Last Transcript : Royalty Pharma plc
| 1 day | +0.92% | ||
| 1 week | +0.13% | ||
| Current month | +5.10% | ||
| 1 month | +5.10% | ||
| 3 months | +11.29% | ||
| 6 months | +29.34% | ||
| Current year | +58.93% |
| 1 week | 60.39 |  | 62.46 |
| 1 month | 56.36 | | 62.46 |
| Current year | 38.29 | | 62.46 |
| 1 year | 34.08 | | 62.46 |
| 3 years | 24.05 | | 62.46 |
| 5 years | 24.05 | | 62.46 |
| 10 years | 24.05 | | 62.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pablo Legorreta
CEO | Chief Executive Officer | 62 | 01/01/1996 |
Terrance Coyne
DFI | Director of Finance/CFO | 44 | 01/01/2010 |
Eric Schneider
CTO | Chief Tech/Sci/R&D Officer | - | 21/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Pablo Legorreta
CHM | Chairman | 62 | 01/04/2020 |
Gregory Norden
BRD | Director/Board Member | 68 | 11/02/2020 |
Bonnie Bassler
BRD | Director/Board Member | 63 | 16/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 19/08/26 | Don | Executive/Senior Manager | -16,800 | 0.0038% | ||
| 13/08/26 | Sell | Chief Financial Officer | -11,002 | 0.0025% | ||
| 07/08/26 | Don | Chief Financial Officer | -18,500 | 0.0754% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.92% | +0.13% | +69.78% | +105.94% | 27.1B | |
| -1.52% | -7.86% | +57.90% | +111.09% | 1,047B | |
| -0.82% | -1.62% | +50.05% | +62.37% | 646B | |
| +0.37% | -3.22% | +21.87% | +72.88% | 451B | |
| -1.64% | -4.75% | +35.59% | +35.54% | 355B | |
| -0.39% | -2.76% | +21.39% | +38.01% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -0.59% | -3.15% | +49.83% | +67.70% | 234B | |
| -1.05% | -2.29% | -19.91% | -54.10% | 203B | |
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | |
| Average | -0.19% | -2.48% | +31.79% | +54.23% | 368.64B | |
| Weighted average by Cap. | -0.00% | -3.44% | +37.15% | +65.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.5B 3.01B 2.83B 2.58B 4.84B 333B 4.88B 33.47B 13.02B 169B 13.13B 12.84B 559B | 3.81B 3.28B 3.08B 2.81B 5.28B 362B 5.32B 36.46B 14.18B 184B 14.3B 13.99B 609B |
| Net income | 1.47B 1.27B 1.19B 1.09B 2.04B 140B 2.05B 14.07B 5.47B 70.95B 5.52B 5.4B 235B | 1.79B 1.54B 1.45B 1.32B 2.49B 171B 2.5B 17.17B 6.68B 86.61B 6.74B 6.59B 287B |
| Net Debt | 9.11B 7.84B 7.37B 6.73B 12.62B 867B 12.72B 87.2B 33.91B 440B 34.21B 33.46B 1,456B | 9.22B 7.94B 7.45B 6.81B 12.77B 877B 12.87B 88.25B 34.32B 445B 34.61B 33.86B 1,473B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/08/26 | $61.41 | +0.92% | 3,564,236 |
| 28/08/26 | $60.85 | -1.73% | 1,701,654 |
| 27/08/26 | $61.92 | +0.19% | 2,094,005 |
| 26/08/26 | $61.80 | -0.43% | 1,478,067 |
| 25/08/26 | $62.07 | +1.21% | 1,705,153 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RPRX Stock
Select your edition
All financial news and data tailored to specific country editions
